The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Emerging evidence is showing a range of beneficial effects for GLP‐1 receptor agonists and especially SGLT‐2 inhibitors on the cardio‐renal axis in patients with type 2 diabetes (T2D) and cardiovascular diseases (CVD). Preliminary findings suggest that: 1‐ such benefit extends also to patients with T2D without pre‐existing CVD; and 2‐ background therapies do not modify the effect of these drugs. Given...
Das metabolische Syndrom – ein Cluster von Stoffwechselkrankheiten und Hypertonie – ist keine neue Krankheit, sondern lässt sich bereits in allen Hochkulturen bei der Oberschicht mit Nahrungsüberschuss und Bewegungsmangel nachweisen. In der medizinischen Literatur taucht es in der Renaissance- und Barockzeit auf. Gegenwärtig erleben wir einen globalen Tsunami, da Überernährung und Bewegungsmangel...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.